CVS Caremark

Gene and genetically modified cellular therapies are getting more sophisticated – and expanding beyond rare and ultrarare diseases. Get a glimpse of what the future of these breakthrough therapies could bring in our new Insights article. https://cvs.co/4eXctxQ #BreakthroughTherapies #DrugPipeline

Some patients have been taking their specialty medications for years. So, we knew we had to communicate early and often about the biosimilars included in the CVS Caremark template formulary. See how we helped patients embrace the change: https://cvs.co/3ZjxEWq

We’re about to see another big year for the U.S. biosimilar market in 2025, when eight biosimilar alternatives to Stelara (ustekinumab) are expected to launch. This represents an opportunity to increase competition and reduce specialty costs. As we saw with Humira biosimilars, educating members and providers about the clinical efficacy and safety of these products will be crucial to help ensure a smooth transition to more affordable alternatives. Read more here: https://cvs.co/4eM2z1S

Championing solutions to address health disparities and advance health equity in communities across the country, CVS Caremark and CVS Specialty have achieved the first URAC Equity Accreditation. We’re honored to share this important milestone in our commitment to health care quality and safety.

Do you know the impact of the flu on business? Flu and flu-like illnesses have a serious impact on employees' ability to work. This affects employers' bottom lines and the society that relies on the goods, products and services. Most Caremark members can get their no-cost flu and COVID-19 vaccines at a pharmacy near them at https://cmk.co/flu6.

Medicare is complex. We’re here to demystify this topic with resources that help health plans and their members make informed decisions. 🎬 In this educational video on the Medicare Prescription Payment Plan, you’ll learn ● how the new program works ● who might and might not benefit from opting in

Go to cmk.co/afford1 to learn how we make affordable medication a reality for CVS Caremark members.

While some people do have success losing weight on a ketogenic or keto diet, this highly restrictive eating plan is not for everyone. Ketogenic diets can pose risks to people with certain health conditions and can contribute to nutrient deficiencies. Adherence is an issue, as well. Many people find the diet difficult and unrealistic to sustain over a long term. Hear more from Dan Knecht, MD MBA, VP, Chief Clinical Innovation Officer, CVS Caremark, and visit https://cvs.co/3Ar9u2J #AskCaremark

Bringing medications within reach for millions of Americans. 💊 At CVS Caremark, we couldn’t do the work we do without independent pharmacies. 🤝 Our diverse network of 65,000 local, regional and national pharmacies supports a healthy pharmacy ecosystem. 💫

The CVS Caremark team will be at the 70th Annual Employee Benefits Conference on November 10-13 in San Diego, CA. Stop by booth #607/609, and let’s talk about TrueCost, biosimilars and GLP-1s helping to lower overall costs with our integrated solutions and deliver better health outcomes. See you there!